WHO ICTRP trial
Efficacy and complication of Duloxetine in attention deficeit –hyperactivity…
IRCT201110127462N2 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT201110127462N2 |
|---|---|
| Public title | Efficacy and complication of Duloxetine in attention deficeit –hyperactivity disorder (ADHD) and comparison with Ritalin |
| Scientific title | Efficacy and complication of Duloxetine in attention deficeit –hyperactivity disorder (ADHD) and comparison with Ritalin |
| Primary sponsor | Tehran University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | attention deficiency hyperactivity disorder. Disturbance of activity and attention;Disturbance of activity and attention |
| Interventions | Intervention 1: Intervention group: Duloxetine 1/4 capsule in the first week, 1/2 capsule in second week, 3/4 capsule in third week and 1 capsule in fourth week. Intervention 2: Control group: according to Ritalin dosage 0.4-1.3 mg/kg… |
| Registration date | Oct 19, 2011 |
| Target size | 40 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: